Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $1.65 is 65.00% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 1.70||$ 2.92|
|Low:||$ 1.61||$ 1|
Company Description (as filed with the SEC)
We are an innovative biopharmaceutical company dedicated to developing novel medicines for people with cancer. We combine proven scientific expertise with a passion for developing novel small molecule drugs that target disease pathways for potential applications in oncology. We are focused on advancing IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate that selectively inhibits the enzyme phosphoinositide-3-kinase-gamma, or PI3K-gamma. We believe IPI-549 is the only clinical-stage selective inhibitor of PI3K-gamma currently being investigated. Selective inhibition of PI3K-gamma by IPI-549 targets tumor-associated myeloid cells, thereby reducing pro-tumor macrophage function and increasing anti-tumor macrophage function. ... More ...
Nasdaq Official Price
Jul. 18, 2019
Jul. 18, 2019